scispace - formally typeset
D

David D. Gutterman

Researcher at Medical College of Wisconsin

Publications -  312
Citations -  20463

David D. Gutterman is an academic researcher from Medical College of Wisconsin. The author has contributed to research in topics: Vasodilation & Endothelium. The author has an hindex of 71, co-authored 293 publications receiving 17963 citations. Previous affiliations of David D. Gutterman include United States Department of Veterans Affairs & Georgetown University.

Papers
More filters
Journal ArticleDOI

Executive Summary : Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

TL;DR: The eighth iteration of the American College of Chest Physicians Antithrombotic Guidelines presented, in a paper version, a narrative evidence summary and rationale for the recommendations, a small number of evidence profiles summarizing bodies of evidence, and some articles with quite extensive summary tables of primary studies.
Journal ArticleDOI

Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines: Report From an American College of Chest Physicians Task Force

TL;DR: An American College of Chest Physicians task force formulated the criteria for a grading system to be utilized in all ACCP guidelines that included simplicity and transparency, explicitness of methodology, and consistency with current methodological approaches to the grading process.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines

TL;DR: Evidence for screening in susceptible patient groups and the approach to diagnosing PAH when it is suspected are reviewed, and specific recommendations for applying this evidence to clinical practice are provided.